Effectiveness of Combined Tobacco Treatment in Hospitalized Subjects
Conditions: Tobacco Smoking; Tobacco Withdrawal; Nicotine Addiction; Nicotine Withdrawal; Nicotine Replacement Therapy Interventions: Drug: Bupropion Sponsors: National Institute of Respiratory Diseases, Mexico Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 12, 2024 Category: Research Source Type: clinical trials
Trial of Naltrexone/Bupropion for the Treatment of Methamphetamine Use Disorder
Conditions: Methamphetamine-dependence; Methamphetamine Abuse Interventions: Drug: extended-release naltrexone (XR-NTX); Drug: extended release bupropion (BUP-XL) tablets (BUP-XL); Drug: iPLB; Drug: oPLB Sponsors: National Institute on Drug Abuse (NIDA) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 31, 2024 Category: Research Source Type: clinical trials
A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
Conditions: Major Depressive Disorder Interventions: Drug: AXS-05; Drug: Bupropion Sponsors: Axsome Therapeutics, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 25, 2024 Category: Research Source Type: clinical trials
Effect of Naltrexone Hydrochloride ER and Bupropion Hydrochloride ER Combination (Contrave ®/Mysimba®) on Major Adverse Cardiovascular Events (MACE)
Conditions: Obesity Interventions: Drug: Naltrexone-Bupropion (NB) Combination; Drug: Placebo Sponsors: Currax Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 24, 2023 Category: Research Source Type: clinical trials
Voxelotor CYP and Transporter Cocktail Interaction Study
Condition: Sickle Cell Disease Interventions: Drug: Voxelotor; Drug: Bupropion; Drug: Repaglinide; Drug: Flurbiprofen; Drug: Omeprazole; Drug: Midazolam; Drug: Metformin; Drug: Furosemide; Drug: Rosuvastatin Sponsor: Pfizer Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2023 Category: Research Source Type: clinical trials
Phase Ib/2a Drug-drug Interaction Study of a Combination of 45mg Dextromethorphan With 105 mg Bupropion
Conditions: Addiction; Opioid Use; Substance Use Disorders; Opioid Use Disorder Interventions: Drug: Placebo; Drug: Auvelity Sponsors: Virginia Commonwealth University; National Institute on Drug Abuse (NIDA) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 4, 2023 Category: Research Source Type: clinical trials